JP Patent

JP6368756B2 — ハロフェナートまたはハロフェン酸および第２の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法

Assigned to CymaBay Therapeutics Inc · Expires 2018-08-01 · 8y expired

What this patent protects

Patent listed against Uloric.

Drugs covered by this patent

Patent Metadata

Patent number
JP6368756B2
Jurisdiction
JP
Classification
—
Expires
2018-08-01
Drug substance claim
No
Drug product claim
No
Assignee
CymaBay Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.